JANNA NICKOLL: Open Payments
NPI 1376070847 · BLOOMINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$527 in 28 payments from 16 companies in 2025. Trend: 2023 $829 · 2024 $738 · 2025 $527
Food & beverage: $527
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Corium, LLC | 2 | $47 |
| Phathom Pharmaceuticals, Inc. | 2 | $40 |
| ABBVIE INC. | 2 | $32 |
| Lilly USA, LLC | 2 | $31 |
| Astellas Pharma US Inc | 1 | $31 |
| Lundbeck LLC | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
Products named: Wegovy, JARDIANCE, TRELEGY ELLIPTA, Azstarys, VOQUEZNA, VRAYLAR, Ozempic, Veozah.
Industry payments across IN — which companies pay providers there.
